Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.

The article presents clinical recommendations of the European Society for Medical Oncology (ESMO) for the diagnosis, treatment and follow-up of non-small-cell lung cancer. Its pathological diagnosis is in accordance to the World Health Organization classification. Staging and risk assessment may include a complete history and physical examination, chest x-ray and computed tomography. Its treatment includes cisplatin-based adjuvant chemotherapy, postoperative radiotherapy and platinum-based chemotherapy.